Key result
Spontaneous reperfusion in STEMI is linked to ~65% lower MACE risk vs no reperfusion.
Why the study?
Spontaneous reperfusion occurs in approximately 20% of STEMI patients before PCI, but the drivers mediating it were unknown.
Does spontaneous reperfusion improve major adverse cardiovascular events in patients with STEMI?
Cohort (n=801)
No
Does spontaneous reperfusion improve major adverse cardiovascular events in patients with STEMI?
Hazard Ratio: 0.35 (95% CI 0.14–0.97)
Absolute Event Rate: 4.1% vs 10.6%
p-value: p=0.024
Spontaneous reperfusion in STEMI is associated with a favorable thrombotic profile and significantly improved long-term clinical outcomes.
BACKGROUND Spontaneous reperfusion, seen in ∼20% of patients with ST-segment elevation myocardial infarction (STEMI), manifests as normal epicardial flow in the infarct-related artery, with or without ST-segment resolution, before percutaneous coronary intervention (PCI). The drivers mediating this are unknown. OBJECTIVES The authors sought to relate spontaneous reperfusion to the thrombotic profile. METHODS In a prospective study, blood from STEMI patients (n = 801) was tested pre-PCI to assess in vitro, point-of-care, occlusion times (OT) and endogenous lysis times (LT). Spontaneous reperfusion was defined as infarct-related artery Thrombolysis In Myocardial Infarction flow grade 3 before PCI. Patients were followed for major cardiovascular events (death, myocardial infarction, or stroke). RESULTS Spontaneous reperfusion was associated with a longer OT (435 seconds vs 366 seconds; P < 0.001) and a shorter LT (1,257 seconds vs 1,616 seconds; P < 0.001), lower troponin, and better left ventricular function. LT was superior to OT for predicting spontaneous reperfusion (area under the curve for LT: 0.707; 95% CI: 0.661-0.753; area under the curve for OT: 0.629; 95% CI: 0.581-0.677). Among patients with spontaneous reperfusion, those with complete, vs partial ST-segment resolution, had a longer OT (P = 0.002) and a shorter LT (P < 0.001). Spontaneous reperfusion was unrelated to clinical characteristics or pain-to-angiography times. Over 4 years, patients with spontaneous reperfusion experienced fewer major adverse cardiovascular events than those without (4.1% vs 10.6%; P = 0.013), especially in those with both spontaneous reperfusion and complete ST-segment resolution (1.5% vs 10.1%; P = 0.029). CONCLUSIONS We demonstrate a novel hematological signature in STEMI patients with spontaneous reperfusion, namely, decreased platelet reactivity and faster endogenous fibrinolysis, relating to smaller infarcts and improved survival. This finding indicates a role for modulating thrombotic status early after STEMI onset, to facilitate spontaneous reperfusion and improve outcomes.
No takes yet. Share an insight, caveat, or question.
Kanji et al. (2023) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=801). Spontaneous reperfusion vs. No spontaneous reperfusion was evaluated on Major adverse cardiovascular events (MACE: death, myocardial infarction, or stroke) (HR 0.35, 95% CI 0.14-0.97, p=0.024). Spontaneous reperfusion in STEMI patients was associated with a 65% reduction in major adverse cardiovascular events compared to no spontaneous reperfusion (HR 0.35).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: